Terminated
Serotonin/Dopamine Antagonism of Cocaine Effect
Led by National Institute on Drug Abuse (NIDA) · Updated on 2017-01-16
N/A
Participants Needed
1
Research Sites
N/A
Total Duration
On this page
Sponsors
N
National Institute on Drug Abuse (NIDA)
Lead Sponsor
V
VA Boston Healthcare System
Collaborating Sponsor
AI-Summary
What this Trial Is About
The purpose of this study is to evaluate use of risperidone with cocaine abusers. Study measures incorporate an appropriate integration of behavioral and neurobiological indices.
CONDITIONS
Official Title
Serotonin/Dopamine Antagonism of Cocaine Effect: 2 - 2
Who Can Participate
Eligibility Criteria
You may qualify if you...
Cocaine abuse or dependence
You will not qualify if you...
Dependence on other drugs. Major psychiatric illness
Trial Site Locations
Total: 1 location
1
Brown University School of Medicine
Providence, Rhode Island, United States, 2906
Status Unknown
How is the study designed?
Study Type
INTERVENTIONAL
Masking
DOUBLE
Allocation
RANDOMIZED
Model
N/A
Primary Purpose
TREATMENT
Number of Arms
0
Not the Right Trial for You?
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here